Terns Pharmaceuticals (TERN) Q3 2024 Earnings

5AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.42
-0.38
-0.33
-0.29

Details

Expected EPS
-0.339097
Actual EPS
-0.31
Surprise EPS
0.03
Surprise Percent
+8.58%

Description

Terns Pharmaceuticals (TERN) has reported earnings of -0.31 per share for Q3 2024.

0 Comments

Share your thoughts